장덕_서브상단배너

Home > 치료사례 > 연구논문

연구논문

이미지명

Case Series of Non-small Cell Lung Cancer Treated With Mountain Ginseng Pharmacopuncture

J Acupunct Meridian Stud 2011;4(1):61−68

 

Case Series of Non-small Cell Lung Cancer Treated With Mountain Ginseng Pharmacopuncture


Ki-Rok Kwon1*, Hyundo Kim2, Jung-Sun Kim3, Hwa-Seung Yoo3, Chong-Kwan Cho3


1Research Center of Korean Pharmacopuncture Institute, Seoul, Korea
2Department of Clinical Sciences, National University of Health Sciences, USA
3East-West Cancer Center, Dunsan Oriental Hospital, Daejeon University, Daejeon, Korea

 

Abstract
This study aims to observe the efficacy of mountain Ginseng (Panax ginseng C.A. Meyer) pharmacopuncture (MGP) on cancer patients using different delivery methods of acupoint injection and intravenous infusion. Six non-small cell lung cancer (NSCLC) patients who met the eligibility criteria were observed. Two patients were continuously infused with MGP (20 mL/day) intravenously, and the other two patients were injected with MGP (10 mL/day) on acupoint LU1 bi-lateral continuously. The
remaining two patients received MGP therapy using both methods of delivery. Results were followed by computed tomography (CT) after every cycle; each cycle lasted for 28 days. Two patients infused intravenously showed stable disease and two patients
injected on LU1 showed progressive disease. Two patients treated using both methods showed stable disease during the intravenous infusion period and progressive disease during the intraacupuncture injection period. One patient showed progressive
disease in the latest chest CT in spite of receiving MGP intravenous infusion. We suggested that MGP may be more effective when used as an intravenous infusion rather than acupoint injection in NSCLC patients.

 

KEY WORDS: acupoint injection; intravenous infusion; mountain Ginseng pharmacopuncture (MGP); non-small cell lung cancer

게시글 공유 URL복사
댓글[0]

열기 닫기